Free Trial
→ $100 Trillion “AI Metal” Found in American Ghost Town (From Brownstone Research) (Ad)tc pixel

Oxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down - What's Next?

Written by MarketBeat
September 29, 2025
Oxford BioMedica logo with Medical background

Key Points

  • Oxford BioMedica's shares gapped down from a previous close of $7.91 to open at $7.30 on Monday, with a trading volume of 400 shares.
  • The company's 50-day simple moving average is $6.81, and the 200-day simple moving average is $5.02, indicating a potential trend in stock price movements.
  • Oxford BioMedica is a contract development and manufacturing organization that focuses on innovative therapies, utilizing its LentiVector platform technology for gene delivery systems.
  • MarketBeat previews top five stocks to own in October.

Oxford BioMedica (OTCMKTS:OXBDF - Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $7.91, but opened at $7.30. Oxford BioMedica shares last traded at $7.30, with a volume of 400 shares traded.

Oxford BioMedica Stock Performance

The stock's 50 day simple moving average is $6.81 and its 200-day simple moving average is $5.02.

Oxford BioMedica Company Profile

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oxford BioMedica Right Now?

Before you consider Oxford BioMedica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford BioMedica wasn't on the list.

While Oxford BioMedica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.